• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec16
Keji Pharmaceutical-B repurchased 1,010,000 shares for HKD14.762 million
13:53
Dec11
Keji Pharmaceutical-B Repurchased 1,020,000 Shares
12:16
Guo Huaqing Reduced 10,000 Shares of Keji Pharmaceutical
11:10
Dec1
Keji Pharmaceuticals-B Repurchased 173,500 Shares
13:46
Nov25
Non-executive Director Guo Huaqing Buys Shares in Celltrion
11:05
Nov24
Keji Pharmaceutical-B Repurchased 360,000 Shares for HKD 5.9567 Million
11:24

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 27.89 M, Net Income -41.31 M, EPS -0.0749

Mar18
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 17.6 M, Net Income -237.54 M, EPS -0.4329

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 3.406 M, Net Income -188.88 M, EPS -0.339

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
09963
0.840
+55.56%
+0.300
08429
0.075
+41.51%
+0.022
08091
0.045
+40.63%
+0.013
01842
0.070
+37.25%
+0.019
00756
0.460
+31.43%
+0.110
08573
0.080
+29.03%
+0.018
03639
0.056
+27.27%
+0.012
00465
0.690
+21.05%
+0.120
08411
0.081
+20.90%
+0.014
00653
0.134
+15.52%
+0.018
View More